Publicacións (25) Publicacións de Carlota Rodríguez García

2024

  1. Analysis of the quality of e-Consultations in chronic obstructive pulmonary disease

    Respiratory Medicine, Vol. 222

  2. Hypersensitivity pneumonitis: application of a new diagnostic algorithm to a time series of the disease

    Expert Review of Respiratory Medicine, Vol. 18, Núm. 3-4, pp. 237-243

2023

  1. A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost‑effectiveness study

    Annals of Thoracic Medicine, Vol. 18, Núm. 4, pp. 190-198

  2. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  3. Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

    Respiratory Medicine, Vol. 214

  4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  5. Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?

    Journal of Thoracic Disease, Vol. 15, Núm. 2, pp. 711-717

  6. Proceso asistencial para el diagnóstico y tratamiento del paciente con déficit de alfa-1 antitripsina (DAAT)

    Conselleria de Sanidade

  7. The Challenge of Diagnosing COPD in Individuals Who Have Never Smoked

    Chest

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  2. Cost-Effectiveness of a New Outpatient Pulmonology Care Model Based on Physician-to-Physician Electronic Consultation

    Canadian Respiratory Journal, Vol. 2022

  3. Response to inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa

    Clinical Respiratory Journal, Vol. 16, Núm. 11, pp. 768-773

  4. Risk factors for chronic obstructive pulmonary disease in never-smokers: A systematic review

    Clinical Respiratory Journal, Vol. 16, Núm. 4, pp. 261-275

2021

  1. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  2. Health Outcomes: Towards the Accreditation of Respiratory Medicine Departments

    Archivos de Bronconeumologia

  3. Health outcomes: Towards the accreditation of respiratory medicine departments

    Archivos de Bronconeumologia, Vol. 57, Núm. 10, pp. 637-647

2020

  1. Asthma Control: A Continuing Challenge

    Open Respiratory Archives

  2. Common errors in inhalation therapy: Impact and solutions

    Clinical Respiratory Journal, Vol. 14, Núm. 11, pp. 1001-1010

  3. Difficulties With Inhaled Therapy: A Complex Simple Technique

    Archivos de Bronconeumologia, Vol. 56, Núm. 7, pp. 416-417

  4. Impact of hyponatremia on COPD exacerbation prognosis

    Journal of Clinical Medicine, Vol. 9, Núm. 2